All Trp53-/-Rbpj-/- mutants had brain tumors, and Trp53-/-Notch1-/-Notch2-/- mutants had either tumor (50%) or hyperplasia (36%) (Figure 1E). This evidence concerns the gene RBPJ and neoplasm.